# About VitaPro Peptides — An Independent Longevity-Research Desk

> About VitaPro Peptides: an independent literature digest on two Longevity & Cellular Health research compounds. How it is compiled, and what it is not — not a seller, not a clinic, not medical advice.

An independent, citation-anchored digest of the longevity-compound literature. Not a vendor. Not a clinic. Not medical advice.

## What VitaPro Peptides is

VitaPro Peptides is an independent editorial reference desk covering the published research on two compounds studied for **longevity and cellular health**: MOTS-c and NAD+. MOTS-c is the lead — a novel mitochondrially-encoded peptide with a rich preclinical story and limited but growing human biomarker data. NAD+ is the energy coenzyme with the longer human trial record. The site exists to make a sometimes-scattered, sometimes-overstated literature legible: to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The organizing idea is the mitochondrial connection. Both molecules tie to mitochondrial biology — MOTS-c is literally encoded in the mitochondrial genome, and NAD+ is the coenzyme that powers mitochondrial respiration and feeds the enzymes that regulate mitochondrial function. Reading them together gives a richer picture of the cellular machinery longevity research is trying to understand.

## How it is compiled

Three principles govern what appears on this site.

*First, everything is anchored to the peer-reviewed literature.* Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs or PubMed/PMC links — collected on the [references page](/references). Where a finding comes from a review rather than a primary study, the review is cited as such.

*Second, the evidence is reported at its true strength.* Doses are described in the species and route in which they were studied — for example, "studied at 5 mg/kg in mice" — never scaled to humans or offered as a recommendation. Where evidence is preclinical, observational, or rests on a precursor molecule rather than the compound itself, the page says so plainly. That candor about limits is not a disclaimer bolted to the bottom; it is part of the information.

*Third, the two pages are cross-referenced.* Because the same theme — mitochondrial energy sensing and aging biology — runs through both compounds, the pages link to one another so a reader can follow a mechanism from one molecule to the other.

## What it is not

VitaPro Peptides is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any research compound, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person.

The compounds discussed here span different regulatory categories. MOTS-c is a research chemical, not approved for human use and prohibited in sport. NAD+ and its precursors are sold as dietary supplements but are not approved drugs; compounded injectable forms carry their own risks. Readers interested in any condition described in the underlying research should consult a licensed clinician operating within their own jurisdiction, working with regulated, evidence-based options. The value this site offers is a calm, accurate map of the literature — nothing more, and nothing it pretends to be.

---

A literature digest tracing mitochondrial-linked longevity research — citations on record, never a product in hand.